Skip to main content
Clinical Trials/NCT06967441
NCT06967441RecruitingNot Applicable

Respiratory Virus Infections in Hospitalized Patients With Acute Heart Failure Syndrome: A Prospective Multi-center Observational Study

Minjae Yoon3 sites in 1 country360 target enrollmentStarted: April 7, 2025Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Sponsor
Enrollment
360
Locations
3
Primary Endpoint
Respiratory virus PCR detection rate

Study Overview

Brief Summary

Patients admitted to the cardiology department with acute heart failure who have a nasopharyngeal respiratory virus PCR test performed within 72 hours of admission will be enrolled in the study cohort.

The detection rate of respiratory viruses including influenza virus, RSV, and coronavirus will be analysed. The investigators will also look for seasonal changes in the frequency of respiratory viruses and differences in the clinical presentation of heart failure based on respiratory virus infection.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
19 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Adult aged 19 years or older admitted to the cardiology department with acute heart failure
  • •NT-proBNP >300 pg/mL
  • •Clinician judgement of possible respiratory viral infection (fever >38 degrees or cough, respiratory symptoms such as sputum or consolidation on x-ray or CRP >5 mg/dL)
  • •Patients who have a nasopharyngeal swab for respiratory virus PCR test performed within 72 hours of admission for any of the 3 reasons

Exclusion Criteria

  • •Patients with a clear other cause of acute heart failure (ex. ACS, bradycardia requiring a pacemaker, uncontrolled tachycardia, uncontrolled severe hypertension (SBP >180mmHg or DBP >110mmHg), haemoglobin <7g/dL or AHF precipitated by medication non-adherence)
  • •If the cause of pulmonary oedema is prominently attributed to exacerbation of CKD
  • •If there is a clear other source of infection that can explain the fever

Outcomes

Primary Outcomes

Respiratory virus PCR detection rate

Time Frame: Within 3 days of admission

Respiratory virus PCR detection rate (especially RSV, influenza virus) in acute HF

Secondary Outcomes

  • Rehospitalization(12month)
  • Days of hospitalization(From admission to discharge during index hospitalization (upto 30 days))
  • Rate of ICU care or ventilation(From admission to discharge during index hospitalization (upto 30 days))
  • In hospital mortality(From admission to discharge during index hospitalization (upto 30 days))
  • mortality(12 month)

Investigators

Sponsor
Minjae Yoon
Sponsor Class
Other
Responsible Party
Sponsor Investigator
Principal Investigator

Minjae Yoon

Assistant professor

Seoul National University Bundang Hospital

Study Sites (3)

Loading locations...

Similar Trials